Investor Relations

Press Releases

October 30, 2026

Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded

October 20, 2026

Media Update: UEG Week: Sanofi and Teva’s duvakitug maintained long-term positive outcomes in new phase 2b data for ulcerative colitis and Crohn’s disease

Read the Media Update

October 19, 2026

Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Read the Press Release

See more press releases

Upcoming Events

10Nov

2026

Wolfe Research Healthcare Conference 2026 – New York

Conferences

17Nov

2026

Jefferies Global Healthcare Conference – London

Speaker: Thomas Triomphe, Executive Vice President, Vaccines

Conferences

Discover more

24Nov

2026

Leerink Partners East Coast (POLARxPRESS) Bus Tour 2026 – Boston

Speaker: Manuela Buxo, Executive Vice President, Head of Specialty Care

Conferences

All our events

Female, Senior Unit Head, Drug Product Development, wearing a white lab coat and safety glasses and purple gloves, smiles while working at her lab computer

Kirsten Strahlendorf, Senior Unit Head, Drug Product Development, Toronto Campus, Canada

2025 20-F

Presenting our 2025 FORM 20-F.

Dividend (in euros) per share

31st Consecutive Year of Dividend Increase

Learn more

Dividend (in dollars) per ADR (½ share)

Learn more

Dr. Yohana Mokiwa has a serious expression, blue shirt and stethoscope, as he speaks with a patient in a pop up clinic

Dr. Yohana Mokiwa speaking with a patient in a pop-up clinic, Dar es Salaam, Tanzania

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.